GLOBAL RESEARCH Bombshell: CDC No Longer Recognizes the PCR Test As a Valid Method for Detecting “Confirmed Covid-19 Cases”
THE BIG NEWS (*):
In the Course of the Next FOUR Days the RT-PCR Test in the US will be Declared Invalid?
In a bombshell decision, the Centers for Disease Control and Prevention (CDC) have withdrawn the insidious PCR test as a valid method for detecting and identifying SARS-CoV-2.
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.”
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing. (emphasis added)
It has taken them almost two years to recognize that the PCR test is flawed and invalid.
Read carefully, what this CDC directive admits is that the PCR test cannot differentiate between “SARS-CoV-2 and influenza viruses”. We have known this from the outset.
This advisory by the CDC issued in July 2021 is to be enforced in the course of the next couple of weeks leading up to the January 1st, 2022 deadline.
Will it be carried out?? Visibly there is no transition towards “another authorized Covid-19 test”.
_______________________________